Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD issues advice on cascade use of antibiotics
antibiotics
VMD has released a position statement in response to concerns over antibiotic use on the cascade.
Vets report conflict between responsible use and legal requirements

The Veterinary Medicines Directorate (VMD) is calling for professional bodies, veterinary schools and research institutes to work together to help vets make a more informed choice when prescribing antibiotics on the cascade.

Veterinary surgeons have raised concerns with the VMD about the difficulty of balancing the responsible use of antibiotics with legal requirements to prescribe UK authorised medicines before applying the cascade.

According to the VMD, vets are reporting an increasingly common challenge - where there is an authorised medicine that is a critically important antibiotic (CIA) and/or is not narrow spectrum. Under legislative requirements, this should be used as a first line treatment, rather than an unauthorised, non-CIA drug.

However, in some cases, other products authorised for use in other EU member states may be more appropriate in terms of the responsible use of antibiotics.

In response to these concerns, the VMD has issued its position statement on prescribing antibiotics under the cascade.

On a case-by-case basis, the directorate says it is "justified" to to prescribe an antibiotic on the cascade to reduce the development of resistance.

Vets must demonstrate that they have considered the most appropriate active substance(s), formulation, posology, current patterns of resistance in their locality, awareness of how to reduce selection pressure and other factors, such as good biosecurity, husbandry, hygiene and avoidance of surgical sepsis.

VMD is calling for the industry to collaborate on compiling up-to-date evidence and guidance to help vets make an informed choice based on scientific evidence and peer reviewed data.

Vets are also advised to keep up-to-date with the latest guidance provided by organisations including the BVA, BSAVA, BEVA, Pig Veterinary Society and Responsible Use of Medicines in Agriculture.

For the full position statement, see the VMD website: http://www.vmd.defra.gov.uk/pdf/cascade.pdf

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com